Swiggy has raised a whopping $1.25 billion from SoftBank and Prosus, while the rival plant-based protein players have both launched chicken analogs.
A new report from the investor group examines how 10 major animal health companies are tackling – or failing to tackle – antibiotic resistance in animal agriculture.
“We’ve reached an inflection point on climate adaptation, and there’s a growing sense of urgency around preparing supply chains,” said CEO Himanshu Gupta.
Shiok Meats is planning to open a production facility in its native Singapore by 2023 to cultivate cell-based shrimp, lobster, crab, and crayfish at commercial scale.
I’m drowning in new food! Can someone please restructure me out of this mess?